Compare KDP & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KDP | KVUE |
|---|---|---|
| Founded | 1981 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Specialty Chemicals |
| Sector | Consumer Staples | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.5B | 33.1B |
| IPO Year | 1993 | 2023 |
| Metric | KDP | KVUE |
|---|---|---|
| Price | $28.08 | $17.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 12 |
| Target Price | ★ $35.06 | $20.00 |
| AVG Volume (30 Days) | 11.0M | ★ 34.2M |
| Earning Date | 02-24-2026 | 02-05-2026 |
| Dividend Yield | 3.32% | ★ 4.88% |
| EPS Growth | N/A | ★ 35.31 |
| EPS | ★ 1.16 | 0.75 |
| Revenue | ★ $16,174,000,000.00 | $15,006,000,000.00 |
| Revenue This Year | $8.12 | N/A |
| Revenue Next Year | $4.70 | $2.81 |
| P/E Ratio | $23.94 | ★ $22.75 |
| Revenue Growth | ★ 6.77 | N/A |
| 52 Week Low | $25.03 | $14.02 |
| 52 Week High | $36.12 | $25.17 |
| Indicator | KDP | KVUE |
|---|---|---|
| Relative Strength Index (RSI) | 51.71 | 53.60 |
| Support Level | $27.48 | $16.56 |
| Resistance Level | $28.01 | $17.20 |
| Average True Range (ATR) | 0.42 | 0.25 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 71.33 | 63.58 |
Keurig Dr Pepper was established in 2018 following a merger between Keurig Green Mountain Coffee and Dr Pepper Snapple. The company manufactures and distributes coffee systems (including coffee brewers and single-serve coffee pods) under the Keurig and Green Mountain brands, as well as ready-to-drink beverages including flavored (non-cola) sparkling soft drinks under well-known brands such as Dr Pepper, Snapple, and Canada Dry. The company controls production and route to market for its own brands through in-house manufacturing plants and distribution infrastructure and leverages these facilities to manufacture and distribute for third-party coffee and beverage brands via licensing and partnership agreements. The US and Canada make up 95% of revenue, with the rest from Mexico.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.